Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Clinical Trials

Pfizer and Merck to Collaborate on Study Evaluating Novel Anti-Cancer Combination Regimen

Pfizer Inc. (NYSE:PFE) and Merck & Co. Inc. (NYSE: MRK), known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizer’s crizotinib (XALKORI®) with Merck’s investigational anti-PD-1 antibody pembrolizumab, in...

Posted today in New Drug Approvals

FDA Approves New Indication for Promacta (eltrombopag) for Severe Aplastic Anemia

26 August 2014 -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta (eltrombopag) in patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).1 SAA...

Posted yesterday in New Drug Approvals

Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain

PHILADELPHIA, August 25, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved Zorvolex (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis...

Posted today in Medical

Health Highlights: Aug. 26, 2014

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Blood Pressure Controlled Best by Patient: Study Patients with hypertension who monitored their own blood pressure at home, and adjusted their medications accordingly, had better blood pressure readings after a year than those who were under the...

Posted today in Medical

Health Tip: Preparing for the First Day of School

-- Your child may be excited yet anxious about school, especially if he or she is going to a new school. The American Academy of Pediatrics suggests how to help your child prepare: Remind your child about the positives of going to school, such as seeing old friends. Talk with your child about what he or she is feeling. Explain that most children...

Posted today in Medical

Health Tip: Do You Talk in Your Sleep?

-- Talking during sleep can affect your ability to feel rested the next day, not to mention that it can keep your partner awake. The National Sleep Foundation suggests how to help prevent talking during sleep: Stick to a consistent sleep schedule. Make sure you get enough sleep each night. Avoid alcohol and eating before bed. Manage your stress. ...

Posted today in Medical

Everest Study Finds High Altitude Affects Blood Pressure

In a new study done from the heights of Mount Everest, Italian researchers found that your blood pressure steadily increases if you ascend to great heights. They also found that a drug widely used to treat high blood pressure was ineffective once climbers reached above a certain altitude. The findings, reported online Aug. 27 in the European Heart...

Posted today in Medical

Scientists Spot Genetic Clues to Crohn's Disease

A new genetic discovery about Crohn's disease could lead to different ways to fight the bowel disorder, researchers report. The scientists pinpointed chemical changes in Crohn's patients' DNA that affect how their genes work, and said these changes can be detected in blood samples. Along with raising the possibility of a simple diagnostic test for...

Posted today in Medical

Sleep Apnea Treatment Helps Seniors, Study Finds

A new study finds that continuous positive airway pressure (CPAP) is an effective treatment for seniors with sleep apnea. CPAP is widely used to treat moderate to severe obstructive sleep apnea, a condition in which the airway relaxes and narrows during sleep, causing breathing problems and interrupted sleep that leads to daytime drowsiness. CPAP...

Posted today in Medical

Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids?

There's been controversy for years over whether the use of common antidepressants by women during their pregnancies might raise the odds of mental health issues in their children. Now, a study involving more than 13,000 children finds no rise in the risk of autism in children whose mothers used an antidepressant while pregnant, but some data suggesting...

Read more news...

Recently added consumer and prescribing information: Triumeq, Arnuity Ellipta, Cerdelga, Jardiance, Plegridy, Belsomra, Invokamet, Striverdi Respimat, Zydelig, Targiniq ER

Posted in Blog

Fox News Features Drugs.com Medication Guide app

Thanks to Fox News for showcasing the Drugs.com Medication Guide app today. Very much appreciated. Available in both the Apple App store and the Google Play store, this is a great app for ultra-quick research and/or keeping track of multiple meds. Check out the video at the link below… http://www.foxnews.com/health/2014/07/13/drugscom-app-provides-medical-information-on-go/ And check out the apps here… http://www.drugs.com/apps/

Posted in Blog

Heartbleed Update

Drugs.com utilizes the Akamai content delivery network to serve our website to end users. Akamai patched the announced Heartbleed vulnerability prior to its public announcement. Akamai, like all users of OpenSSL, could have exposed passwords or session cookies transiting our network from August 2012 through 4 April 2014. Their custom memory allocator protected against nearly […]

Posted in Blog

Consumer Reports Gives the Thumbs Up to the Drugs.com Pill Identifier App

Consumer Reports just put out a review of seven pill identifier apps. Here’s a snippet… “We reviewed seven apps that can help identify the pills you take, and liked two of them a lot: Drugs.com Pill Identifier and Epocrates Pill ID. The others—CVS/Pharmacy Pill Identifier, iPharmacy Pill Identifier, Pill Finder, Prescription Pill Identifier, and ID […]

See more blog posts or follow us on twitter.

Hide
(web3)